Front Endocrinol 14:1207537 Zhu ML, Zhang J, Guo LJ, Yue RZ, Li SS, Cui BY et al (2023) Amorphous selenium inhibits oxidative stress injury of neurons in vascular dementia rats by activating NMDAR pathway
Assessment of drug safety GLP-1GIPLani also decreased body weight, fat mass and food intake with increased effectiveness compared with co-treatment with GLP-1GIP plus Lani, without affecting lean tissue mass (Fig
It is associated with increased mortality in patients with chronic kidney disease [21]
Not for human or veterinary use, not for diagnostic or therapeutic use, and not for consumption
doi: 10.1016/s0092-8674(03)00429-x
Regulatory concerns prompted the inclusion of pancreatitis warnings in the prescribing information for all approved GLP-1 agonists